Loading the records…
Loading the records…
The ACE Agriculture Act (HR7142) permanently authorizes AGARDA through FY2032 and expands its sustainability goals, but authorizes zero direct funding. This is a long-term policy signal for precision ag and water-saving tech, not a near-term catalyst. Recent stock moves for $DE, $AGCO, and $SMG show no correlation with this procedural bill.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Zero near-term market implications. at $563.86, $AGCO at $120.41, and at $65.38 are trading on earnings, crop prices, and input costs — not on a procedural authorization bill with no funding. The bill is too early-stage and too funding-absent to move any stock. Investors should monitor the appropriations process in FY2027 (October 2026) for actual AGARDA budget numbers before assigning any value to this policy signal.
What happened: On January 16, 2026, Rep. Panetta (D-CA) introduced HR7142, the ACE Agriculture Act, in the 119th Congress. It was referred to the House Committee on Agriculture, where it remains in early committee stage with no further action. The bill permanently authorizes the Agriculture Advanced Research and Development Authority (AGARDA) through FY2032 and expands its goals to include water conservation, greenhouse gas mitigation, and resilience to drought and disease.
The money trail: Authorization of programs is a policy action — it sets maximum spending ceilings but allocates NO actual budget. AGARDA's funding still requires a separate annual Appropriations bill from the House and Senate Appropriations Committees. The bill text contains zero dollar figures. Without an appropriation, AGARDA has no money to distribute to researchers, universities, or companies.
Structural winners and losers: As a long-term policy signal, the bill favors precision agriculture technology providers (, $AGCO) and companies involved in irrigation efficiency and water management. However, without funding, there is no near-term contract revenue. No company loses from this bill — it is purely directional.
Real market data: As of April 30, 2026, traded at $563.86 (down 2.78% over 7 days); $AGCO at $120.41 (up 3.69% over 7 days); and at $65.38 (up 2.54% over 7 days). These moves reflect general sector conditions and company-specific factors — not the ACE Act. The bill has had zero measurable market impact since its introduction.
Timeline: The bill is at the earliest legislative stage — referred to committee with three total actions. It requires committee markup, House floor vote, Senate companion bill (none exists), passage in both chambers, and presidential signature. Even if enacted, appropriation is a separate multi-year process. Near-term catalysts for the sector are unrelated to this bill.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Authorization of AGARDA through FY2032 with expanded environmental goals including water conservation tech — no direct funding appropriated.
Who must act
USDA ARS and AGARDA program administrators.
What happens
Policy signal for R&D priorities in precision agriculture and water-saving technology, but no contract obligation or new spending allocated. No near-term revenue implications for private firms.
Stock impact
AGCO's Fendt, Massey Ferguson, and precision farming technology platforms align with AGARDA R&D goals, but with zero funding authorized, there is no near-term revenue impact.
Matched on shared policy language across AI analyses, with ticker & timing weight
United States Grain Standards Reauthorization Act of 2025
Farm Equipment Safety Act
Securing American Agriculture Act
Emergency Conservation Program Improvement Act of 2025
Expedited Guaranteed Lender Pilot Program Act
Buying American Cotton Act of 2025
Farmers Freedom Act of 2025
Improving Drought Monitoring Act
Executive orders & memoranda affecting the same sectors or companies
The President invokes Section 232 of the Trade Expansion Act to declare that imports of robotics, industrial machinery, and their components threaten national security, and directs the Secretary of Commerce and USTR to negotiate agreements with trading partners to adjust these imports, potentially leading to tariffs or quotas within 180 days.
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →